妇科肿瘤学中的财务毒性
本研究在妇科肿瘤随访患者中调查财务毒性(COST量表)与自报整体健康(EQ-VAS)的关联。240名受访者中位COST评分为29分,财务毒性越高自报健康越差(r=0.47;p<0.001)。多变量分析中仅政府资助保险、较低收入及化疗与高财务毒性显著相关,高财务毒性与所有费用应对策略显著相关,包括延迟或回避就医(RR:7.3;95%CI:2.8-19.1)。
要点
- 240名妇科肿瘤随访患者中位COST评分为29分,财务毒性与自报整体健康呈中度相关(r=0.47;p<0.001)。
- 多变量分析中政府资助保险、较低收入及化疗与高财务毒性显著相关。
- 高财务毒性与所有费用应对策略显著相关,延迟或回避就医的RR为7.3(95%CI:2.8-19.1)。
核心结论
- 在保险覆盖程度较高的妇科肿瘤患者中,许多受访者报告了高水平的财务毒性,高财务毒性与较差的自报整体健康及费用应对策略(包括延迟或回避就医)显著相关。
研究设计与样本
- 在妇科肿瘤执业机构中对随访患者进行问卷调查,纳入COST(财务毒性综合评分)工具和EQ-VAS自报整体健康评估,并从病历中摘录疾病与治疗特征,共240名受访者。
主要发现
- 240名受访者中位COST评分为29分;财务毒性越大与自报健康越差相关(r=0.47;p<0.001)。
- 粗分析中,黑人或西班牙裔种族/族裔、政府资助保险、较低收入、失业、宫颈癌及化疗与高财务毒性相关。
- 多变量分析中,仅政府资助保险、较低收入及化疗与高财务毒性显著相关。
- 高财务毒性与所有费用应对策略显著相关,包括延迟或回避就医(RR:7.3;95%CI:2.8-19.1)。
关键数值与推荐
- COST评分被二分为低财务毒性与高财务毒性。
- 高财务毒性与延迟或回避就医的关联RR为7.3(95%CI:2.8-19.1)。
- 财务毒性与自报整体健康的相关系数r=0.47(p<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Financial toxicity is increasingly recognized as an adverse outcome of cancer treatment. Our objective was to measure financial toxicity among gynecologic oncology patients and its association with demographic and disease-related characteristics; self-reported overall health; and cost-coping strategies. METHODS: Follow-up patients at a gynecologic oncology practice completed a survey including the COmprehensive Score for Financial Toxicity (COST) tool and a self-reported overall health assessment, the EQ-VAS. We abstracted disease and treatment characteristics from medical records. We dichotomized COST scores into low and high financial toxicity and assessed the correlation (r) between COST scores and self-reported health. We calculated risk ratios (RR) and 95% confidence intervals (CI) for the associations of demographic and disease-related characteristics with high financial toxicity, as well as the associations between high financial toxicity and cost-coping strategies. RESULTS: Among 240 respondents, median COST score was 29. Greater financial toxicity was correlated with worse self-reported health (r = 0.47; p < 0.001). In the crude analysis, Black or Hispanic race/ethnicity, government-sponsored health insurance, lower income, unemployment, cervical cancer and treatment with chemotherapy were associated with high financial toxicity. In the multivariable analysis, only government-sponsored health insurance, lower income, and treatment with chemotherapy were significantly associated with high financial toxicity. High financial toxicity was significantly associated with all cost-coping strategies, including delaying or avoiding care (RR: 7.3; 95% CI: 2.8-19.1). CONCLUSIONS: Among highly-insured gynecologic oncology patients, many respondents reported high levels of financial toxicity. High financial toxicity was significantly associated with worse self-reported overall health and cost-coping strategies, including delaying or avoiding care.
引用
- Bouberhan S, Shea M, Kennedy A, et al. Financial toxicity in gynecologic oncology. Gynecol Oncol. 2019. PMID: 31053404. doi:10.1016/j.ygyno.2019.04.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。